Kyowa Hakko Kirin Co., Ltd. (4151) – Financial and Strategic SWOT Analysis Review

Date: 2015-12

“Kyowa Hakko Kirin Co., Ltd. (4151) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko), formerly Kyowa Hakko Kogyo Co., Ltd., is a biotechnology company. It focuses on the discovery, development, production and commercialization of pharmaceuticals and biotechnology products. Kyowa Hakko operates through two business segments, namely, Pharmaceuticals and Bio- chemicals. The company’s commercial products comprise for the therapeutic areas of Oncology, Nephrology and others include Gran, Nesp, Espo, Romiplate, Coniel, Regpara, Allelock/Patanol and Depakene/Topina among others. Its development pipeline consists of various protein, antibody and small molecule formulations such as Pegfilgrastim Injection, Cinacalcet Hydrochloride Oral, KW-6002 Istradefylline Oral, AMG531 Romiplostim Injection, Granisetron Patch and others. The products are developed for the treatment of diseases such as, neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and others. The company along with its subsidiaries operates in the US, Europe and Asia. Kyowa Hakko Kirin is headquartered in Tokyo, Japan.

Kyowa Hakko Kirin Co., Ltd. Key Recent Developments

Jul 31, 2015: Kyowa Hakko Kirin Announces Consolidated Financial Results for the Six Months Ended June 30, 2015
Apr 28, 2015: Kyowa Hakko Kirin Announces Consolidated Financial Results for the Three Months Ended March 31, 2015
Mar 31, 2015: Completion of Construction for New Research Building in Fuji Research Park
Mar 16, 2015: Change in the Company Name (trade name) at DAIICHI FINE CHEMICAL
Jan 30, 2015: Kyowa Hakko Kirin: Consolidated Financial Results for the Fiscal Year Ended December 31, 2014

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company”


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample